Yuvraj_pawp, Author at Pharma Advancement

The biomarker specialists at Biomedica Immunoassays, announced the launch of the first CE marked FGF23 (C-terminal) ELISA assay which specifically...

Combination Drug Development and Five Year New Chemical Entity (NCE) Exclusivity

by Yuvraj_pawp

4th April 2015

The US Food and Drug Administration (FDA) recently announced that fixed-combination drugs (FCD) comprised of at least one NCE will...

RSSL Doubles QP Course Dates Following Increased Demand

by Yuvraj_pawp

3rd April 2015

Reading Scientific Services (RSSL) has doubled the number of course places on offer after experiencing significant increases in the number...

Canada’s Valeant buys Salix for $11bn

by Yuvraj_pawp

2nd April 2015

Canada-based Valeant Pharmaceuticals International has completed the acquisition of US-based Salix Pharmaceuticals for around $11bn. Under the deal, Valeant...

Neurocrine, Mitsubishi Tanabe to develop VMAT2 inhibitor NBI-98854 for movement disorders

by Yuvraj_pawp

2nd April 2015

US-based Neurocrine Biosciences has entered into an exclusive collaboration and licensing agreement with Japanese firm Mitsubishi Tanabe Pharma to develop...

Micromeritics Announces Instrument Grant to the University of Georgia

by Yuvraj_pawp

1st April 2015

Micromeritics' Instrument Grant Committee has recently selected its latest grant recipient. A TriStar II Plus 3030, NanoPlus 3 and Flowprep...

Particulate Systems Acquires Subsieve Autosizer (SAS) from HEL

by Yuvraj_pawp

1st April 2015

Particulate Systems, a brand of Micromeritics, has completed the full acquisition of Subsieve Autosizer from HEL. The agreement was finalised...

Patheon closes Acqisition of IRIX Pharmaceuticals

by Yuvraj_pawp

1st April 2015

Patheon has closed the acquisition of IRIX Pharmaceuticals, a company that specialises in making difficult to manufacture active pharmaceutical ingredients...

BioCryst gets $35m contract for new Ebola treatment

by Yuvraj_pawp

1st April 2015

BioCryst Pharmaceuticals has received a $35m contract to continue developing BCX4430, a drug that has shown early signs of fighting...

Perrigo completes acquisition of OTC drugmaker Omega Pharma for $4.5bn

by Yuvraj_pawp

1st April 2015

Ireland-based Perrigo has completed the acquisition of Belgium's over-the-counter (OTC) drugmaker Omega Pharma for around €3.8bn ($4.5bn). As part...

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Avadel Pharmaceuticals Receives Orphan Drug Designation from FDA for LUMRYZ™ (sodium oxybate) for Extended-Release Oral Suspension for the Treatment of Idiopathic Hypersomnia

Robots and AI in Drug Discovery Are Transforming Medicine

Stringent Policy around COVID Vaccines Laid by FDA

Pharmaceutical Chemicals Market Booms with Rising API Demand

Next in Pharma 2025: Innovations Shaping the Future

Work Smart: Go for Hands-Free Lab Informatics at the Bench, Not Scribbled Notes and Delayed Documentation at Your Desk

AI Revolutionizing Drug Discovery and Clinical Development

China’s Super Me-Too Drug Development: A New Pharma Frontier

Asia Pacific Omics-Based Clinical Trials Market Growth

Avadel Pharmaceuticals Receives Orphan Drug Designation from FDA for LUMRYZ™ (sodium oxybate) for Extended-Release Oral Suspension for the Treatment of Idiopathic Hypersomnia

Robots and AI in Drug Discovery Are Transforming Medicine

Stringent Policy around COVID Vaccines Laid by FDA

Pharmaceutical Chemicals Market Booms with Rising API Demand

Next in Pharma 2025: Innovations Shaping the Future

Work Smart: Go for Hands-Free Lab Informatics at the Bench, Not Scribbled Notes and Delayed Documentation at Your Desk

AI Revolutionizing Drug Discovery and Clinical Development

China’s Super Me-Too Drug Development: A New Pharma Frontier

Asia Pacific Omics-Based Clinical Trials Market Growth

Yuvraj_pawp

Biomedica Launches First CE Marked FGF23 ELISA Assay In Europe and Asia

Combination Drug Development and Five Year New Chemical Entity (NCE) Exclusivity

RSSL Doubles QP Course Dates Following Increased Demand

Canada’s Valeant buys Salix for $11bn

Neurocrine, Mitsubishi Tanabe to develop VMAT2 inhibitor NBI-98854 for movement disorders

Micromeritics Announces Instrument Grant to the University of Georgia

Particulate Systems Acquires Subsieve Autosizer (SAS) from HEL

Patheon closes Acqisition of IRIX Pharmaceuticals

BioCryst gets $35m contract for new Ebola treatment

Perrigo completes acquisition of OTC drugmaker Omega Pharma for $4.5bn

Qucik Links

About Us

Subscribe Us

System

Resources

Retrieve your password